Recurrent Pericarditis: IL-1 Blockade – Rationale, Evidence Base, and Practical Clinical Pharmacology

Update: 2025-04-22

Description

This vodcast focuses on enhancing healthcare professionals' understanding of the guidelines, current science, and best practices for managing recurrent pericarditis. Experts delve into the rationale for IL-1 blockade, review the evidence base supporting this approach, and discuss the practical clinical pharmacology involved. Learn how these critical aspects can improve patient outcomes in recurrent pericarditis management.

Claim CE:

https://education.heart.org/productdetails/recurrent-pericarditis-exploring-il-1-blockade-rationale-evidence-base-practical-clinical-pharmacology-2

Comments

In Channel

Navigating Recurrent Pericarditis: Shared Decision Making and Patient Stories

2025-06-1832:43

Recurrent Pericarditis: IL-1 Blockade – Rationale, Evidence Base, and Practical Clinical Pharmacology

2025-04-2223:47

Recurrent Pericarditis: Conventional Approaches to Managing Recurrent Pericarditis

2025-03-1927:11

Acute Pericarditis: Management, Pharmacological Strategies and Clinical Therapeutics

2024-10-1626:36

Acute Pericarditis: Clinical Evaluation and Diagnostic Assessment

2024-10-1616:04

Long Term Complications of Recurrent Pericarditis

2022-11-3030:34

Recurrent Pericarditis in Systemic Autoinflammatory and Autoimmune Disease – Clinical Recognition and Management

2022-11-0138:40

Recurrent Pericarditis: The Role of IL-1 Blockade

2022-10-1039:20

Pathophysiology of Recurrent Pericarditis

2022-06-0630:30

Beyond Acute – Recurrent Pericarditis

2022-04-1831:26

Treatment of Acute Pericarditis

2022-02-2540:26

Complications of Acute Pericarditis

2021-12-0733:07

What is Acute Pericarditis: Signs and Signals

2021-10-2533:52

00:00

Recurrent Pericarditis: IL-1 Blockade – Rationale, Evidence Base, and Practical Clinical Pharmacology

American Heart Association

#box-pro-ellipsis-176741116733882{-webkit-line-clamp:2;}Recurrent Pericarditis: IL-1 Blockade – Rationale, Evidence Base, and Practical Clinical Pharmacology

Recurrent Pericarditis: IL-1 Blockade – Rationale, Evidence Base, and Practical Clinical Pharmacology

American Heart Association

Recurrent Pericarditis: IL-1 Blockade – Rationale, Evidence Base, and Practical Clinical Pharmacology